1SXP — SCHOTT Pharma AG & Co KgaA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapMomentum Trap

Annual balance sheet for SCHOTT Pharma AG & Co KgaA, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—
Source:	ARS	ARS	ARS	ARS
Standards:	—	—	—	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	19.3	28.2	30.6	28.4
Net Total Accounts Receivable
Net Total Receivables	153	187	385	285
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	239	302	555	468
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	267	334	517	638
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	596	740	1,197	1,232
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	210	244	323	351
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	281	322	489	541
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	315	418	707	690
Total Liabilities & Shareholders' Equity	596	740	1,197	1,232
Total Common Shares Outstanding